0,00EUR

0,00%

18:29:49

STU

Crescent Biopharma Incorporation Registered Shs für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A41BDZ / ISIN: KYG2545C1042

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Crescent Biopharma Incorporation Registered Shs Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Crescent Biopharma Incorporation Registered Shs

Weitere Meldungen

03:32		Millions of Investors Are About to Own SpaceX Stock Indirectly -- Whether They Want to or Not
03:00		Intel's AI Bet Is Finally Paying Off -- Is It Time to Reconsider This Stock?
02:30		Wall Street Thinks AI Capex Is Unsustainable -- Here's Why Big Tech Keeps Spending Anyway
02:00		This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested
01:19		Hedge Funds Are Buying Up Amazon Stock. Should You Join In, Too?
00:45		The Market Is Panicking, But You Should Keep Buying Shares of This Artificial Intelligence (AI) Powerhouse
00:30		How Many Starlink Satellites Can SpaceX Launch This Year?
00:15		3 Stocks I'm Not Selling No Matter What the Market Does
27.06.26		Accenture Shares Plunged 50% This Year. Here's What Investors Need to Know.
27.06.26		Nike Stock Gets A Rude Awakening As Technicals Point To More Weakness Ahead Of Earnings
27.06.26		Where Will High-Yield Enbridge Stock Be in 10 Years?
27.06.26		Federal Realty Investment Trust vs. Realty Income: Which Real Estate Stock Is a Better Buy in 2026?
27.06.26		SpaceX Looks to Reshuffle the Deck in the Enterprise Coding Market With Its $60 Billion Deal for Cursor
27.06.26		Here's Why Buying Brookfield Renewable Today Could Be the Best Financial Decision You Ever Make
27.06.26		Should Investors Buy Infleqtion to Ride the Quantum Computing Rally?
27.06.26		Restaurant Brands International vs. McDonald's: Comparing Revenue Trends for These Fast-Food Giants
27.06.26		Today's Wordle Hints, Answer and Help for June 28, #1835
27.06.26		UK’s Bridgepoint nears deal to buy real estate unit in bet on US property
27.06.26		UK’s Bridgepoint nears deal to buy real estate unit in bet on US property
27.06.26		Bitcoin Price Stalls at Key Support as ETF Outflows Reach Monthly Record
27.06.26		3 Reasons to Buy Silicon Motion Technology Stock Like There's No Tomorrow
27.06.26		1 Reason Why Passively Managed Index Funds Could Save You More Money Than Mutual Funds
27.06.26		EWY ETF Assets Jump To $23 Billion, But Samsung and SK Hynix Risks Remain
27.06.26		OneSpaWorld Director Sold 10,500 Shares, but Here's What Investors Should Watch Next
27.06.26		Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now
27.06.26		The Big Paint vs Rare Earth Faceoff: One Stock to Buy Right Now for 2026 and Beyond
27.06.26		Warren Buffett's Berkshire Hathaway Is Sitting on Nearly $400 Billion in Cash. Is a Stock Market Crash Coming?
27.06.26		What to Know About This $3.1 Million Check Point Software Insider Sale After Shares Fell 40%
27.06.26		Prediction: Buying Rivian Stock Today Could Set You Up for Life
27.06.26		What to Know About This $1.56 Million Dream Finders Homes Insider Sale After Shares Fell 29%
27.06.26		The Market Just Pulled Back Again. These 3 Blue Chips Are the Ones to Buy.
27.06.26		Larry Ellison’s Net Worth Plunges $45 Billion as Oracle Stock Chart Signals More Downside
27.06.26		SpaceX's Out-of-This-World Plan Has Flaws. That Bodes Well for This Terrestial Stock.
27.06.26		Hungary holds first post-Orban Budapest Pride march
27.06.26		MAGS ETF: Magnificent 7 Outflows Surge as Investors Rotate Into DRAM
27.06.26		Dividend Stock Showdown: NextEra Energy vs. Dominion Energy -- Which Should You Own?
27.06.26		The Fed Removed This 1 Key Phrase From the Inflation Report. What That Means for the Market.
27.06.26		SoFi Stock Is Down Over 30% and Here Is What Investors Should Consider Now
27.06.26		What to Know About This $130,000 Amalgamated Financial Insider Sale After Shares Rose 49%
27.06.26		2 Biotech Stocks Worth Buying Before Their Potential Buyouts
27.06.26		DiamondRock Hospitality Stock Is Up 61%. Here's What This Insider Sale Could Mean
27.06.26		Steven Madden Stock Is Up 81%. Should Investors Care About This Director's Sale?
27.06.26		The Zen of Jensen: Nvidia CEO Says ‘I Let the World Come to Me’
27.06.26		Is PayPal Stock Cheap, or a Value Trap?
27.06.26		Where Will Nvidia Stock Be in 2030?
27.06.26		Intuitive Surgical Stock Is Up Over 400%. Here's Why It's Still a No-Brainer Buy.
27.06.26		A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.
27.06.26		Micron CEO Sanjay Mehrotra Says Watching Berkeley’s ‘The Play’ Helped Shape A Leadership Quality He Later Brought To SanDisk
27.06.26		Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests
27.06.26		What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally

Zurück | 1 | 2 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Orinko Advanced Plastics a Genew Technologies a Kandal M Venture Mahvie Minerals AB Cons of 8 Shs + 4 Wts TO2 Laddu Gopal Online Services

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	28.06.2026 13:37
Kaufwert:	EUR
	Hinzufügen Speichern

Crescent Biopharma Incorporation Registered Shs Aktie

WKN DE: A41BDZ / ISIN: KYG2545C1042

Crescent Biopharma Incorporation Registered Shs Times and Sales (STU)

Times and Sales

Analysen zu Crescent Biopharma Incorporation Registered Shs

Weitere Meldungen